Inhibition of histone deacetylase 1 (HDAC1) could sensitize tumour cells to T‐cell‐mediated immune response17 and stimulate PDL1 expression for enhanced immunotherapy response in cancers.18, 19. The gene discussed is CD274; the disease is neoplasm.